Skip to main content

Calcium Channel Blockers: Inhibitors of Tumor Cell-Platelet-Endothelial Cell Interactions

  • Chapter
Hemostatic Mechanisms and Metastasis

Part of the book series: Developments in Oncology ((DION,volume 22))

Abstract

The movement of calcium ions across cellular membranes (e. g., plasma membrane, endoplasmic or sarcoplasmic reticulum) can serve as a molecular messenger that modulates biochemical processes appropriate to the specific cell type. Calcium antagonists by preventing release of Ca2+ from intracellular stores, by peventing influx of external Ca2+ or by inhibiting the effects of Ca2+ through interactions with Ca2+-binding proteins such as calmodulin can interfere with these biochemical functions. The primary action of one subgroup of calcium antagonists is to interact with the channels in the cell membrane through which calcium enters the cells. This class of compounds originally described by Fleckenstein has been called by a variety of names including Ca2+-channel blockers, Ca2+-entry blockers, Ca2+-channel inhibitors and slow-channel blockers (for review see 1–3). We will use the terminology calcium channel blockers (CCB) in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Fleckenstein A. Annu. Rev. Pharmacol. Toxicol. 17: 149–166, 1977.

    Article  CAS  Google Scholar 

  2. Janis RA and Triggle RJ. J. Med. Chem. 26: 775–785, 1983.

    Article  PubMed  CAS  Google Scholar 

  3. Braunwald E. N. Engl. J. Med. 307: 1618–1627, 1982.

    Article  CAS  Google Scholar 

  4. Murphy KMM, Gould RJ, Largent BL and Snyder SH. Proc. Natl. Acad. Sci. USA 80: 860–864, 1983.

    Article  CAS  Google Scholar 

  5. Nayler WS and Grinwald P. Fed. Proc. Fed. Am. Soc. Exp. Biol. 40: 2855–2861, 1981.

    CAS  Google Scholar 

  6. Lee KS and Tsien RW. Nature (London) 302: 790–794, 1983.

    Article  CAS  Google Scholar 

  7. Janis RA and Scriabine A. Biochem. Pharmacol. 32: 3499–3507, 1983.

    Article  PubMed  CAS  Google Scholar 

  8. Wellens D, Goossens T and Reyntjens A. Angiology 12: 821–827, 1980.

    Article  Google Scholar 

  9. Conti CR. J. Fl. Med. Assoc. 68: 883–886, 1981.

    CAS  Google Scholar 

  10. Murphy KMM and Synder SH. Eur. J. Pharmacol. 77: 201–202, 1982.

    Article  PubMed  CAS  Google Scholar 

  11. Motulsky HJ, Snavely MD, Hughes RJ and Insel PA. Circ. Res. 52: 226–231, 1983.

    PubMed  Google Scholar 

  12. Tsuruo T, Iida H, Tsukagoshi S and Sakurai Y. Cancer Res. 43: 2267–2272, 1983.

    PubMed  CAS  Google Scholar 

  13. Tsuruo T, Iida H, Nojiri M, Tsukagoshi S and Sakurai Y. Cancer Res. 43: 2905–2910, 1983.

    PubMed  CAS  Google Scholar 

  14. Kaelin WG, Shrivastav S, Shand DG and Jirtle RL. Cancer Res. 42: 3944–3949, 1982.

    PubMed  CAS  Google Scholar 

  15. Winquist RJ, Webb RC and Bohr DF. Fed. Proc. Fed. Am. Soc. Exp. Biol. 40: 2852–2854, 1981.

    CAS  Google Scholar 

  16. Honn KV, Menter DG, Onoda JM, Taylor JD and Sloane BF. In: Cancer Invasion and Metastasis (Eds. Nicolson GL and Milas L), Raven Press: New York, pp. 361–388, 1984.

    Google Scholar 

  17. Bastida E, Ordinas A and Jamieson GA. Nature (London) 291: 661–662, 1981.

    Article  CAS  Google Scholar 

  18. Hara Y, Steiner M and Baldini MS. Cancer Res. 40: 1217–1222, 1980.

    PubMed  CAS  Google Scholar 

  19. Karpatkin S, Smerling A and Pearlstein E. J. Lab. Clin. Med. 96: 994–1001, 1980.

    CAS  Google Scholar 

  20. Gasic GJ, Gasic TB and Stewart CC. Proc. Natl. Acad. Sci. USA 61: 46–52, 1968.

    Article  PubMed  CAS  Google Scholar 

  21. Gastpar H, Ambrus J and Thurber LE. J. Med. 8: 53–56, 1977.

    PubMed  CAS  Google Scholar 

  22. Gasic GJ, Gasic TB, Galanti N, Johnson T and Murphy J. Int. J. Cancer 11: 704–718, 1973.

    Article  PubMed  CAS  Google Scholar 

  23. Honn KV, Busse WD and Sloane BF. Biochem. Pharmacol. 32: 1–11, 1983.

    Article  PubMed  CAS  Google Scholar 

  24. Menter DG, Onoda JM, Taylor JD and Honn KV. Cancer Res. 44: 450–456, 1984.

    PubMed  CAS  Google Scholar 

  25. Lerner WA, Pearlstein E, Ambrogio C and Karpatkin S. Int. J. Cancer 31: 463–469, 1983.

    Article  PubMed  CAS  Google Scholar 

  26. Honn KV. Clin. Exp. Metastasis 1: 103–114, 1983.

    Article  CAS  Google Scholar 

  27. Honn KV, Cicone B and Skoff A. Science 212: 1270–1272, 1981.

    Article  PubMed  CAS  Google Scholar 

  28. Owen NE, Feinberg H and Lebreton GC. Am. J. Physiol. 239: H483–H488, 1980.

    PubMed  CAS  Google Scholar 

  29. Owen NE and Lebreton GC. Am. J. Physiol. 241: H613–H619, 1981.

    PubMed  CAS  Google Scholar 

  30. Miller OV, Johnson RA and Gorman RR. Prostaglandins 13: 599–609, 1977.

    Article  PubMed  CAS  Google Scholar 

  31. Gorman RR. Fed. Proc. Fed. Am. Soc. Exp. Biol. 38: 83–88, 1979.

    CAS  Google Scholar 

  32. Fleckenstein A. Arzneim.Forsch./Drug Res. 20: 1317–1322, 1970.

    CAS  Google Scholar 

  33. Godfraind T. Fed. Proc. Fed. Am. Soc. Exp. Biol. 40: 2866–2871, 1981.

    CAS  Google Scholar 

  34. Ono H and Kimura M. Arzneim.Forsch./Drug Res. 31: 1131–1134, 1981.

    CAS  Google Scholar 

  35. Schmunk GA and Lefer AM. Res. Commun. Chem. Pathol. Pharmacol. 35: 179–187, 1982.

    PubMed  CAS  Google Scholar 

  36. Ribeiro LGT, Brandon TA, Horak JK, Ware JA, Miller RR and Solis RT. J. Cardiovas. Pharmacol. 4: 170–173, 1982.

    Article  CAS  Google Scholar 

  37. Han P, Boatwright C and Ardlie NG. Thromb. Haemostas. 50: 513–517, 1983.

    CAS  Google Scholar 

  38. Dale J, Landmark KH and Myhre E. Am. Heart J. 105: 103–105, 1983.

    Article  PubMed  CAS  Google Scholar 

  39. Shinjo A, Sasaki Y, Inamasu M and Morita T. Thromb. Res. 13: 941–955, 1978.

    Article  PubMed  CAS  Google Scholar 

  40. Okamatsu S, Peck RC and Lefer AM. Proc. Soc. Exp. Biol. Med. 166: 551–555, 1981.

    PubMed  CAS  Google Scholar 

  41. Ikeda Y, Kikuchi M, Toyama K, Wantanabe K and Ando Y. Thromb. Haemostasis 45: 158–161, 1981.

    CAS  Google Scholar 

  42. Addonizio VP, Fisher CA, Strauss JF and Edmunds LH. Thromb. Res. 28: 545–556, 1982.

    Article  PubMed  CAS  Google Scholar 

  43. Mehta J, Mehta P, Ostrowski N and Crews F. Thromb. Res. 30: 469–475, 1983.

    Article  PubMed  CAS  Google Scholar 

  44. Maclntyre DE and Shaw AM. Thromb. Res. 21: 833–844, 1983.

    Article  Google Scholar 

  45. Mehta P, tfehta J, Ostrowski N and Brigmon L. J. Lab. Clin. Med. 102: 332–339, 1983.

    CAS  Google Scholar 

  46. Schomerus M, Spiegelhalder B, Stevens B and Eichelbaum K. Cardiovas. Res. 10: 605–612, 1976.

    Article  CAS  Google Scholar 

  47. Foster TS, Hamann SR, Richards VR, Bryant PJ, Graves DA and McAllister RG. J. Clin. Pharmacol. 23: 161–170, 1983.

    CAS  Google Scholar 

  48. Rybicki JP and LeBreton GC. Thromb. Res. 30: 407–414, 1983.

    Article  PubMed  CAS  Google Scholar 

  49. Onoda JM, Sloane BF and Honn KV. Submitted.

    Google Scholar 

  50. Honn KV, Onoda JM, Diglio CA, Carufel MM, Taylor JD and Sloane BF. Clin. Exp. Metastasis, in press.

    Google Scholar 

  51. Honn KV, Onoda JM, Diglio CA and Sloane BF. Proc. Soc. Exp. Biol. Med. 174: 16–19, 1983.

    CAS  Google Scholar 

  52. Honn KV, Onoda JM, Pampalona K, Battaglia M, Neagos G, Taylor JD, Diglio CA and Sloane BF. Submitted.

    Google Scholar 

  53. Gerold M, Eigenmann R and Haeusler G. J. Cardiovas. Pharmacol. 4: 419–429, 1982.

    Article  CAS  Google Scholar 

  54. Norman JA, Ansell J and Phillips MA. Eur. J. Pharmacol. 93: 107–112, 1983.

    Article  PubMed  CAS  Google Scholar 

  55. Bostrum SL, Ljung B, Mardh S, Forsen S and Thulin E. Nature (London) 292: 777–778, 1981.

    Article  Google Scholar 

  56. Srivastava KC and Awasthi KK. Prostaglandins Leukotrienes Med. 10: 411–417, 1983.

    Article  CAS  Google Scholar 

  57. Maniglia CA, Tudor G, Gomez J and Sartorelli AC. Cancer Lett. 16: 253–260, 1982.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Onoda, J.M., Sloane, B.F., Taylor, J.D., Honn, K.V. (1984). Calcium Channel Blockers: Inhibitors of Tumor Cell-Platelet-Endothelial Cell Interactions. In: Honn, K.V., Sloane, B.F. (eds) Hemostatic Mechanisms and Metastasis. Developments in Oncology, vol 22. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3831-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3831-4_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3833-8

  • Online ISBN: 978-1-4613-3831-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics